NCT04522505View on ClinicalTrials.gov

Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus Nephritis

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

November 29, 2017

Primary Completion Date

February 7, 2024

Study Completion Date

July 22, 2024

Conditions
Lupus Nephritis
Trial Locations (1)

04763

Hanyang university hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Hanyang University

OTHER

lead

Corestemchemon, Inc.

INDUSTRY

NCT04522505 - Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus Nephritis | Biotech Hunter | Biotech Hunter